These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 18566313)

  • 21. Cardiac regenerative therapy: Many paths to repair.
    Gude NA; Sussman MA
    Trends Cardiovasc Med; 2020 Aug; 30(6):338-343. PubMed ID: 31515053
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neoangiogenesis after combined transplantation of skeletal myoblasts and angiopoietic progenitors leads to increased cell engraftment and lower apoptosis rates in ischemic heart failure.
    Bonaros N; Rauf R; Werner E; Schlechta B; Rohde E; Kocher A; Bonatti J; Laufer G
    Interact Cardiovasc Thorac Surg; 2008 Apr; 7(2):249-55. PubMed ID: 17925321
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-Term Engraftment of Human Cardiomyocytes Combined with Biodegradable Microparticles Induces Heart Repair.
    Saludas L; Garbayo E; Mazo M; Pelacho B; Abizanda G; Iglesias-Garcia O; Raya A; Prósper F; Blanco-Prieto MJ
    J Pharmacol Exp Ther; 2019 Sep; 370(3):761-771. PubMed ID: 30728248
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The challenges for cardiac vascular precursor cell therapy: lessons from a very elusive precursor.
    Roura S; Gálvez-Montón C; Bayes-Genis A
    J Vasc Res; 2013; 50(4):304-23. PubMed ID: 23860201
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stem cell-mediated neovascularization in heart repair.
    Nesselmann C; Li W; Ma N; Steinhoff G
    Ther Adv Cardiovasc Dis; 2010 Feb; 4(1):27-42. PubMed ID: 20042449
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Paracrine effects of cell transplantation: modifying ventricular remodeling in the failing heart.
    Fedak PW
    Semin Thorac Cardiovasc Surg; 2008; 20(2):87-93. PubMed ID: 18707639
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The cardiovascular unit as a dynamic player in disease and regeneration.
    Ausoni S; Sartore S
    Trends Mol Med; 2009 Dec; 15(12):543-52. PubMed ID: 19913457
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enabling technologies for homing and engraftment of cells for therapeutic applications.
    Singh JP
    JACC Cardiovasc Interv; 2009 Aug; 2(8):803-4. PubMed ID: 19695551
    [No Abstract]   [Full Text] [Related]  

  • 29. Stem cells for the treatment of heart failure.
    Menasché P; Vanneaux V
    Curr Res Transl Med; 2016; 64(2):97-106. PubMed ID: 27316393
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardiac regenerative potential of adipose tissue-derived stem cells.
    Hoke NN; Salloum FN; Loesser-Casey KE; Kukreja RC
    Acta Physiol Hung; 2009 Sep; 96(3):251-65. PubMed ID: 19706369
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The bone marrow--cardiac axis of myocardial regeneration.
    Liao R; Pfister O; Jain M; Mouquet F
    Prog Cardiovasc Dis; 2007; 50(1):18-30. PubMed ID: 17631435
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biologic properties of endothelial progenitor cells and their potential for cell therapy.
    Young PP; Vaughan DE; Hatzopoulos AK
    Prog Cardiovasc Dis; 2007; 49(6):421-9. PubMed ID: 17498522
    [TBL] [Abstract][Full Text] [Related]  

  • 33. State-of-play for cellular therapies in cardiac repair and regeneration.
    Vaka R; Davis DR
    Stem Cells; 2021 Dec; 39(12):1579-1588. PubMed ID: 34448513
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Application of injectable hydrogels for cardiac stem cell therapy and tissue engineering.
    Alagarsamy KN; Yan W; Srivastava A; Desiderio V; Dhingra S
    Rev Cardiovasc Med; 2019 Dec; 20(4):221-230. PubMed ID: 31912713
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Imaging: guiding the clinical translation of cardiac stem cell therapy.
    Nguyen PK; Lan F; Wang Y; Wu JC
    Circ Res; 2011 Sep; 109(8):962-79. PubMed ID: 21960727
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of Extracellular Matrix in Cardiac Cellular Therapies.
    Hematti P
    Adv Exp Med Biol; 2018; 1098():173-188. PubMed ID: 30238371
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardiac Stem Cell Patch Integrated with Microengineered Blood Vessels Promotes Cardiomyocyte Proliferation and Neovascularization after Acute Myocardial Infarction.
    Su T; Huang K; Daniele MA; Hensley MT; Young AT; Tang J; Allen TA; Vandergriff AC; Erb PD; Ligler FS; Cheng K
    ACS Appl Mater Interfaces; 2018 Oct; 10(39):33088-33096. PubMed ID: 30188113
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardiovascular regenerative therapeutics via synthetic paracrine factor modified mRNA.
    Lui KO; Zangi L; Chien KR
    Stem Cell Res; 2014 Nov; 13(3 Pt B):693-704. PubMed ID: 25043723
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Uterine-derived progenitor cells are immunoprivileged and effectively improve cardiac regeneration when used for cell therapy.
    Ludke A; Wu J; Nazari M; Hatta K; Shao Z; Li SH; Song H; Ni NC; Weisel RD; Li RK
    J Mol Cell Cardiol; 2015 Jul; 84():116-28. PubMed ID: 25939780
    [TBL] [Abstract][Full Text] [Related]  

  • 40. RETRACTED: Recent advances in cardiac regeneration: Stem cell, biomaterial and growth factors.
    Cheraghi M; Namdari M; Negahdari B; Eatemadi A
    Biomed Pharmacother; 2017 Mar; 87():37-45. PubMed ID: 28040596
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.